Rumbleon Inc

Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration

Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Skeena Gold & Silver Announces Pricing of US$750 Million Senior Secured Notes Offering to Refinance Former Project Financing and to Fund Partial Buyback of Existing Gold Stream

Lindsay Corporation Reports Fiscal 2026 Second Quarter Results

Sally Beauty Holdings Appoints Adrianne Lee as Chief Financial Officer